We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
iShares Morningstar Growth ETF
ILCG
$3.06B
| $739K | ﹤0.01% |
+9,790
| New | +$705K |
|
|
CTV
1752
DELISTED
Innovid Corp.
CTV
| $736K | ﹤0.01% |
295,515
+187,620
| +174% | +$325K |
|
1753
Jin Medical International
ZJYL
$15M
| $734K | ﹤0.01% |
+9,554
| New | +$1.4M |
|
1754
Entrada Therapeutics
TRDA
$226M
| $733K | ﹤0.01% |
+51,723
| New | +$731K |
|
1755
Smith & Nephew
SNN
$13.7B
| $729K | ﹤0.01% |
+28,762
| New | +$789K |
|
|
SUM
1756
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $728K | ﹤0.01% |
+16,338
| New | +$646K |
|
1757
Methode Electronics
MEI
$525M
| $725K | ﹤0.01% |
+59,521
| New | +$1.12M |
|
|
LX
1758
LexinFintech Holdings
LX
$241M
| $725K | ﹤0.01% |
402,571
-173,212
| -30% | -$320K |
|
1759
Shutterstock
SSTK
$220M
| $724K | ﹤0.01% |
+15,800
| New | +$753K |
|
1760
Hamilton Beach Brands
HBB
$323M
| $722K | ﹤0.01% |
+29,653
| New | +$575K |
|
1761
Inovio Pharmaceuticals
INO
$84.7M
| $722K | ﹤0.01% |
+51,983
| New | +$449K |
|
1762
Ameresco
AMRC
$1.04B
| $717K | ﹤0.01% |
+29,713
| New | +$666K |
|
1763
Myriad Genetics
MYGN
$502M
| $715K | ﹤0.01% |
+33,557
| New | +$721K |
|
1764
iShares MSCI Spain ETF
EWP
$2.08B
| $714K | ﹤0.01% |
+22,190
| New | +$667K |
|
1765
Dime Commercial Bancshares
DCOM
$1.8B
| $714K | ﹤0.01% |
+37,063
| New | +$781K |
|
1766
Lincoln Educational Services
LINC
$1.33B
| $712K | ﹤0.01% |
68,918
-19,347
| -22% | -$188K |
|
1767
Minerals Technologies
MTX
$2.33B
| $708K | ﹤0.01% |
+9,408
| New | +$660K |
|
1768
Rapid7
RPD
$642M
| $701K | ﹤0.01% |
+14,300
| New | +$785K |
|
1769
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
| $700K | ﹤0.01% |
+29,072
| New | +$681K |
|
1770
Wabtec
WAB
$51.7B
| $699K | ﹤0.01% |
+4,800
| New | +$650K |
|
1771
Vericel Corp
VCEL
$2.39B
| $697K | ﹤0.01% |
+13,406
| New | +$588K |
|
|
ASBPW
1772
CALL
Aspire Biopharma Warrant
ASBPW
$579K
| $697K | ﹤0.01% |
62,081
-137,917
| -69% | -$5.39K |
|
1773
Scilex Holding
SCLX
$48M
| $697K | ﹤0.01% |
+12,517
| New | +$730K |
|
|
MTLS
1774
Materialise
MTLS
$373M
| $696K | ﹤0.01% |
131,769
-56,834
| -30% | -$319K |
|
1775
Upbound Group
UPBD
$1.26B
| $696K | ﹤0.01% |
19,759
-910
| -4% | -$30.4K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.